rs768324201

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong

The NM_017934.7(PHIP):​c.328C>T​(p.Arg110Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R110S) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

PHIP
NM_017934.7 missense

Scores

13
3
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 9.36

Publications

7 publications found
Variant links:
Genes affected
PHIP (HGNC:15673): (pleckstrin homology domain interacting protein) This gene encodes a protein that binds to the insulin receptor substrate 1 protein and regulates glucose transporter translocation in skeletal muscle cells. The encoded protein may also regulate growth and survival of pancreatic beta cells. Elevated copy number of this gene may be associated with melanoma severity and the encoded protein may promote melanoma metastasis in human patients. [provided by RefSeq, Oct 2016]
PHIP Gene-Disease associations (from GenCC):
  • developmental delay, intellectual disability, obesity, and dysmorphic features
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr6-79060679-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1301421.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.859
PP5
Variant 6-79060680-G-A is Pathogenic according to our data. Variant chr6-79060680-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 975951.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHIPNM_017934.7 linkc.328C>T p.Arg110Cys missense_variant Exon 5 of 40 ENST00000275034.5 NP_060404.4 Q8WWQ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHIPENST00000275034.5 linkc.328C>T p.Arg110Cys missense_variant Exon 5 of 40 1 NM_017934.7 ENSP00000275034.3 Q8WWQ0

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000206
AC:
3
AN:
1459452
Hom.:
0
Cov.:
30
AF XY:
0.00000413
AC XY:
3
AN XY:
726042
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33350
American (AMR)
AF:
0.00
AC:
0
AN:
44332
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26000
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39660
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85864
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53368
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1110864
Other (OTH)
AF:
0.00
AC:
0
AN:
60270
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.001814), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.342
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Mar 23, 2022
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29209020, 28263302, 27479843) -

Aug 08, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 110 of the PHIP protein (p.Arg110Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with PHIP-related conditions (PMID: 29209020). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 975951). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHIP protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Jan 21, 2019
Molecular Genetics laboratory, Necker Hospital
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome Pathogenic:2
Oct 01, 2024
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Criteria applied: PS2_MOD,PS4_MOD,PM5,PM2_SUP,PP2 -

Jan 23, 2025
Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Pathogenic:1
Mar 20, 2018
Ambry Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability Pathogenic:1
-
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PHIP-related disorder Pathogenic:1
Aug 06, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The PHIP c.328C>T variant is predicted to result in the amino acid substitution p.Arg110Cys. This variant has been reported as a de novo variant in at least one patient with intellectual disability, developmental delays, behavioral problems, and dysmorphic facial features (Individual 10, Supplemental note, Jansen et al. 2018. PubMed ID: 29209020; Table S2, Lelieveld et al. 2016. PubMed ID: 27479843), and was also reported as de novo in a patient with autism spectrum disorder (Table S3, Yuen et al. 2017. PubMed ID: 28263302). At PreventionGenetics, we have also observed this variant to occur de novo in a patient with clinical features consistent with a PHIP-related disorder (internal data). Additionally, a different de novo variant affecting the same amino acid (p.Arg110Ser) has been reported in an individual with similar features (Individual 5, Supplemental note, Jansen et al. 2018. PubMed ID: 29209020). We interpret this variant as likely pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.16
CADD
Pathogenic
33
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.66
D
Eigen
Pathogenic
0.92
Eigen_PC
Pathogenic
0.91
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.055
D
MetaRNN
Pathogenic
0.86
D
MetaSVM
Benign
-0.84
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
9.4
PrimateAI
Pathogenic
0.93
D
PROVEAN
Pathogenic
-6.8
D
REVEL
Uncertain
0.60
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.82
MutPred
0.58
Loss of MoRF binding (P = 0.003);
MVP
0.82
MPC
2.9
ClinPred
1.0
D
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.59
gMVP
0.81
Mutation Taster
=13/87
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768324201; hg19: chr6-79770397; COSMIC: COSV51504515; API